Russia and Japan are partners in the treatment of oncological diseases

On March 2, 2020, an agreement was signed between the National Medical Research Center for Radiology of the Ministry of Health of Russia and Toshiba for cooperation in the development of a Heavy Ion Therapy System in Russia

Toshiba Energy Systems & Solutions Corporation

Kawasaki, Japan-Toshiba Energy Systems & Solutions Corporation (hereinafter “Toshiba ESS”) today announced the signing of a general framework agreement with the National Medical Research Center of Radiology (hereinafter “NMIC of Radiology”) on the introduction of a heavy ion therapy system in Russia.

Russia and Japan have developed an “eight-point cooperation plan”*, one of the key points of which is “medical care”. It is expected that the use of methods such as heavy ion therapy for the treatment of oncological diseases will contribute to an increase in the life expectancy of the country’s residents in the future.

Toshiba ESS is developing heavy ion therapy systems. The first project where Toshiba ESS participated in the development and planning of a heavy ion medical accelerator was the project of the National Institute of Quantum and Radiological Science and Technology (QST/NIRS) in Chiba (HIMAC), where treatment with this method began in 1994. Toshiba ESS provided the system for HIMAC and Kanagawa Cancer Center, and also installed it at Yamagata University Hospital. Outside of Japan, the system is currently being built for the Yonsei University Health System (YUHS) in Korea.

In order to introduce a heavy ion therapy system in Russia and meet the expectations associated with the experience and technologies of Toshiba ESS, Toshiba ESS Corporation and NMRRC have reached an agreement on the use of a heavy ion radiotherapy system for the treatment of oncological diseases in Russia.

Toshiba ESS will continue to participate in the supply of advanced medical equipment, such as a heavy ion therapy system, so that cancer patients around the world can choose various options for high-quality treatment.

* This plan was proposed by Japan to Russia during the Japan-Russia Summit in May 2016.

Photos from the signing ceremony

A.D. Kaprin (center right), CEO of NMIC Radiology and Goro Yanase (center left), Director, Head of the Nuclear Division of Toshiba ESS